Abstract: Described herein are devices and methods for treating degenerative joint diseases with electromagnetic fields using one or more waveforms that are configured to modulate Ca2+ binding to calmodulin and thereby modulate calmodulin-dependent nitric oxide signaling within joint and other affected tissue for the purpose of reducing pain and inflammation, as well as enhancing the healing and regeneration of such tissue.
Type:
Grant
Filed:
April 5, 2011
Date of Patent:
February 24, 2015
Assignee:
Ivivi Health Sciences, LLC
Inventors:
Arthur A. Pilla, Andre′ A. DiMino, Matthew E. Drummer
Abstract: An apparatus and method for electromagnetic treatment of living tissues and cells comprising: configuring at least one waveform according to a mathematical model having at least one waveform parameter, said at least one waveform to be coupled to a angiogenesis and neovascularization target pathway structure; choosing a value of said at least one waveform parameter so that said at least waveform is configured to be detectable in said angiogenesis and neovascularization target pathway structure above background activity in said target pathway structure; generating an electromagnetic signal from said configured at least one waveform; and coupling said electromagnetic signal to said angiogenesis and neovascularization target pathway structure using a coupling device.
Abstract: Methods and devices for providing electromagnetic field treatment to a subject having a metal-containing implant or prosthesis at or near the treatment site. These treatment methods can include calibrating the treatment devices such that the treatment field provided is not distorted or affected by the presence of metal in the target location. Additionally, embodiments of the invention provide for wearable and adjustable electromagnetic treatment devices with reinforcing support members to maintain the structure of flexible metal applicators, which generate the therapeutic electromagnetic field.
Type:
Grant
Filed:
January 30, 2012
Date of Patent:
January 1, 2013
Assignee:
Ivivi Health Sciences, LLC
Inventors:
Andre' A. DiMino, Matthew E. Drummer, Arthur A. Pilla
Abstract: Larmor Precession makes specific predictions about bound ion dynamics, based upon specific combinations of AC and DC magnetic fields. Especially significant is the fact that the external magnetic field environment determines the overall qualities of resonances or particular changes in bio-effects. Given a target with a particular gyromagnetic ratio, Larmor Precession makes predictions that are determined solely by a magnetic field environment itself. An embodiment according to the present invention comprises specific combinations of AC and DC magnetic fields configured to produce specific bio-effects.
Type:
Grant
Filed:
April 14, 2008
Date of Patent:
March 1, 2011
Assignee:
Ivivi Health Sciences, LLC
Inventors:
Arthur A. Pilla, Andre' DiMino, David J. Muehsam
Abstract: An apparatus and method for electromagnetic treatment for treatment of molecules, cells, tissues, and organs comprising: configuring at least one waveform according to a mathematical model having at least one waveform parameter, said at least one waveform to be coupled to a target pathway structure; choosing a value of said at least one waveform parameter so that said at least waveform is configured to be detectable in said target pathway structure above background activity in said target pathway structure; generating an electromagnetic signal from said configured at least one waveform; and coupling said electromagnetic signal to said target pathway structure using a coupling device wherein said coupling device is an integral portion of a positioning device.
Type:
Grant
Filed:
September 10, 2005
Date of Patent:
July 20, 2010
Assignee:
Ivivi Health Sciences, LLC
Inventors:
Arthur A. Pilla, Andre′ DiMino, Iyer Viswanathan
Abstract: An apparatus and method for electromagnetic treatment of plants, animals, and humans comprising: configuring at least one waveform according to a mathematical model having at least one waveform parameter, said at least one waveform to be coupled to a target pathway structure; choosing a value of said at least one waveform parameter so that said at least waveform is configured to be detectable in said target pathway structure above background activity in said target pathway structure; generating an electromagnetic signal from said configured at least one waveform; and coupling said electromagnetic signal to said target pathway structure using a coupling device.